Protein involved in balancing DNA replication and restarting found

USP50 protein helps balance nuclease and helicase activity during critical processes

Computer illustration of a double helix DNA strand

A protein that is involved in determining which enzymes cut or unwind DNA during the replication process has been identified in a new study.

In a new paper published in Nature Communications, an international team of researchers have found that the protein USP50 supports the DNA replication process by helping to decide the proper use of nucleases or helicases. These enzymes are implemented during the DNA replication process to promote ongoing replication and where the copying machinery runs into problems and needs to restart.

The team led by Professor Jo Morris from the University of Birmingham’s Department of Cancer and Genomic Sciences have identified that USP50 determines which or the many helicases and nucleases are used during ongoing replication, fork restart, and the maintenance of telemores, the DNA-rich protein structures on the ends of chromosomes. The identification of USP50’s role provides a new insight into the DNA replication process and could lead to a greater understanding of how some hereditary conditions develop.

Jo Morris, Professor of Molecular Genetics in the Department of Cancer and Genomic Sciences at the University of Birmingham and corresponding author of the study said:

“Our study concerns how our cells use specific enzymes to support the typical regulation of DNA replication. We found that because there are several different enzymes involved in cleaving and unwinding, cells must regulate which ones they use so that replication can happen properly. We identified that protein USP50 is involved in this regulation.

“This discovery may be an important step to understanding how some hereditary gene changes lead to early onset ageing and cancer.”

Attempted workaround

The study also found that when USP50 is absent during replication activity, cells attempted to use various nucleases and helicases in a less coordinated fashion leading to replication defects in cells.

Professor Morris added: “The finding that cellular nucleases and helicases can stop replication of certain sections of DNA was a surprise – it shows that cells closely co-ordinate their toolkit of DNA-processing enzymes to get DNA replication properly done.”

Professor Simon Reed, Co-Director of the Division of Cancer and Genetics at Cardiff University and a co-founder of Broken String Biosciences, and co-author of the paper said:

"I am truly honoured to have co-authored this paper published in Nature Communications, exploring the critical role of USP50 in safeguarding genome stability. This research sheds light on the complex mechanisms that protect our cells from DNA damage and highlights how these discoveries could shape future therapies. Thank you to my collaborators—together, we've taken another step forward in understanding how our cells function and how we can apply this knowledge to advance medical science."

Notes for editors

  • For media enquiries please contact Tim Mayo, Press Office, University of Birmingham, tel: +44 (0)7815 607 157.
  • The University of Birmingham is ranked amongst the world’s top 100 institutions. Its work brings people from across the world to Birmingham, including researchers, educators and more than 40,000 students from over 150 countries.
  • England’s first civic university, the University of Birmingham is proud to be rooted in of one of the most dynamic and diverse cities in the country. A member of the Russell Group and a founding member of the Universitas 21 global network of research universities, the University of Birmingham has been changing the way the world works for more than a century.
  • The University of Birmingham is a founding member of Birmingham Health Partners (BHP), a strategic alliance which transcends organisational boundaries to rapidly translate healthcare research findings into new diagnostics, drugs and devices for patients. Birmingham Health Partners is a strategic alliance between seven organisations who collaborate to bring healthcare innovations through to clinical application:
    • University of Birmingham
    • University Hospitals Birmingham NHS Foundation Trust
    • Birmingham Women's and Children's Hospitals NHS Foundation Trust
    • Aston University
    • The Royal Orthopaedic Hospital NHS Foundation Trust
    • Sandwell and West Birmingham Hospitals NHS Trust
    • West Midlands Academic Health Science Network
    • Birmingham and Solihull Mental Health NHS Foundation Trust